The company, which has not received any complaints related to the issue, previously discontinued the devices affected by the ...

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case ...

Celltrion Pharm views the agreement as a key milestone in expanding its PFS CMO business globally by leveraging BD’s ...

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

The new test is available on the DxI 9000 and Access 2 Analysers, along with a range of neurodegenerative disease RUO assays.

The team behind BD&J has served clients across the state of California for over two decades and boasts more than 50 years of ...